A detailed history of Tower Research Capital LLC (Trc) transactions in Amedisys Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 2,116 shares of AMED stock, worth $178,738. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,116
Previous 10,403 79.66%
Holding current value
$178,738
Previous $954,000 78.62%
% of portfolio
0.01%
Previous 0.02%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$96.5 - $98.45 $799,695 - $815,855
-8,287 Reduced 79.66%
2,116 $204,000
Q2 2024

Aug 13, 2024

BUY
$90.4 - $96.77 $417,376 - $446,787
4,617 Added 79.8%
10,403 $954,000
Q1 2024

May 15, 2024

BUY
$92.15 - $95.24 $324,552 - $335,435
3,522 Added 155.57%
5,786 $533,000
Q4 2023

Feb 13, 2024

BUY
$91.15 - $95.89 $11,576 - $12,178
127 Added 5.94%
2,264 $215,000
Q3 2023

Nov 14, 2023

SELL
$89.84 - $94.08 $237,806 - $249,029
-2,647 Reduced 55.33%
2,137 $199,000
Q2 2023

Aug 14, 2023

SELL
$73.99 - $92.6 $75,247 - $94,174
-1,017 Reduced 17.53%
4,784 $437,000
Q1 2023

May 09, 2023

BUY
$69.79 - $100.33 $188,223 - $270,590
2,697 Added 86.89%
5,801 $426,000
Q4 2022

Feb 10, 2023

SELL
$80.12 - $105.34 $379,528 - $498,995
-4,737 Reduced 60.41%
3,104 $260,000
Q2 2022

Aug 15, 2022

BUY
$105.12 - $173.85 $251,972 - $416,718
2,397 Added 44.03%
7,841 $825,000
Q1 2022

May 12, 2022

BUY
$124.79 - $178.09 $400,575 - $571,668
3,210 Added 143.69%
5,444 $938,000
Q4 2021

Feb 14, 2022

BUY
$136.32 - $184.41 $6,543 - $8,851
48 Added 2.2%
2,234 $361,000
Q3 2021

Nov 15, 2021

SELL
$149.1 - $270.32 $4,622 - $8,379
-31 Reduced 1.4%
2,186 $326,000
Q2 2021

Aug 16, 2021

BUY
$238.97 - $288.5 $315,679 - $381,108
1,321 Added 147.43%
2,217 $543,000
Q1 2021

May 17, 2021

SELL
$236.62 - $314.16 $2.82 Million - $3.74 Million
-11,902 Reduced 93.0%
896 $237,000
Q4 2020

Feb 16, 2021

SELL
$231.3 - $293.33 $597,910 - $758,258
-2,585 Reduced 16.8%
12,798 $3.75 Million
Q3 2020

Nov 16, 2020

BUY
$199.22 - $248.1 $596,663 - $743,059
2,995 Added 24.18%
15,383 $3.64 Million
Q2 2020

Aug 13, 2020

BUY
$169.77 - $213.81 $2.1 Million - $2.65 Million
12,382 Added 206366.67%
12,388 $2.46 Million
Q1 2020

May 15, 2020

SELL
$137.21 - $202.02 $4,665 - $6,868
-34 Reduced 85.0%
6 $1,000
Q4 2019

Feb 07, 2020

SELL
$122.85 - $167.13 $60,933 - $82,896
-496 Reduced 92.54%
40 $7,000
Q3 2019

Nov 05, 2019

SELL
$117.97 - $137.89 $189,341 - $221,313
-1,605 Reduced 74.96%
536 $70,000
Q2 2019

Aug 13, 2019

BUY
$108.08 - $129.67 $230,642 - $276,715
2,134 Added 30485.71%
2,141 $260,000
Q1 2019

May 14, 2019

SELL
$110.76 - $138.73 $3,765 - $4,716
-34 Reduced 82.93%
7 $1,000
Q4 2018

Feb 14, 2019

BUY
$98.2 - $140.23 $4,026 - $5,749
41 New
41 $5,000
Q2 2018

Aug 15, 2018

SELL
$60.06 - $87.93 $11,351 - $16,618
-189 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$50.51 - $62.74 $9,546 - $11,857
189 New
189 $11,000
Q4 2017

Feb 09, 2018

SELL
$46.45 - $58.49 $113,152 - $142,481
-2,436 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$47.05 - $55.96 $114,613 - $136,318
2,436
2,436 $136,000

Others Institutions Holding AMED

About AMEDISYS INC


  • Ticker AMED
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 32,492,000
  • Market Cap $2.74B
  • Description
  • Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal...
More about AMED
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.